CO78 Matching-Adjusted Indirect Comparison of Futibatinib Versus Chemotherapy and Pemigatinib in Cholangiocarcinoma Patients With FGFR2 Fusions/Rearrangements
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.157
https://www.valueinhealthjournal.com/article/S1098-3015(22)02361-0/fulltext
Title :
CO78 Matching-Adjusted Indirect Comparison of Futibatinib Versus Chemotherapy and Pemigatinib in Cholangiocarcinoma Patients With FGFR2 Fusions/Rearrangements
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02361-0&doi=10.1016/j.jval.2022.09.157
First page :
Section Title :
Open access? :
No
Section Order :
11180